Navigation Links
Elsevier's Maturitas publishes clinical guide on endometrial assessment in postmenopausal women

Amsterdam, May 8, 2013 Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a clinical guide by the European Menopause and Andropause Society (EMAS) in the journal Maturitas on endometrial assessment in peri and postmenopausal women with summary recommendations.

The main onus of endometrial assessment is to exclude carcinoma of the endometrium and premalignant endometrial hyperplasia. Assessment of the endometrium in the absence of bleeding should be limited to women at high risk of endometrial cancer. Transvaginal ultrasound scanning (TVS) is used for initial assessment to be followed by endometrial biopsy to be undertaken as an outpatient procedure if possible. Hysteroscopy allows direct visualization of the endometrial cavity and any focal lesions. Should results be inconclusive and abnormal or postmenopausal bleeding persist, transvaginal ultrasound should be repeated and hysteroscopy performed.

These and other recommendations presented in EMAS' clinical guide are published in the article: 'EMAS clinical guide: Assessment of the endometrium in peri and postmenopausal women', by Eva Dreisler, Lars Grnlund Poulsen, Sofie Leisby Antonsen, Iuliana Ceausu, Herman Depypere, C. Tamer Erel, Irene Lambrinoudaki, Faustino R. Prez-Lpez, Tommaso Simoncini, Florence Tremollieres, Margaret Rees and Lian Ulrich (10.1016/j.maturitas.2013.03.011).The article appears in Maturitas Volume 75, Issue 2 (June 2013), published by Elsevier.


Contact: Greyling Peoples

Page: 1

Related biology news :

1. Leading RSV researcher publishes work at Le Bonheur Childrens
2. PeerJ publishes its first articles
3. Mercury releases contaminate ocean fish: Dartmouth-led effort publishes major findings
4. Professor publishes on first-ever imaging of cells growing on spherical surfaces
5. NYBG press publishes final volume of landmark Intermountain Flora series
6. The ENCODE Project publishes new genomic insights in special issue of Genome Research
7. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
8. Clinical Tests Demonstrate Long-Term Effectiveness of Oral Glutathione Supplements - Kyowa Study
9. Genetic and clinical factors best to predict late recurrence in estrogen receptor POS breast cancer
10. Federal Government Organization achieves cleaner and faster Clinical Study Data using Tablet PCs from TabletKiosk
11. AACR news: Paragazole excels in preclinical models of triple-negative breast cancer
Post Your Comments:
(Date:6/15/2016)... 15, 2016 Transparency Market ... Recognition Market by Application Market - Global Industry Analysis Size ... to the report, the  global gesture recognition market ... and is estimated to grow at a CAGR ... 2024.  Increasing application of gesture recognition ...
(Date:6/3/2016)... LONDON , June 3, 2016 /PRNewswire/ ... Transport Management) von Nepal ... ,Angebot und Lieferung hochsicherer geprägter Kennzeichen, einschließlich ... weltweit führend in der Produktion und Implementierung ... an der Ausschreibung im Januar teilgenommen, aber ...
(Date:6/1/2016)... Favorable Government Initiatives Coupled With ... Identification to Boost Global Biometrics System Market Through 2021  ... report, " Global Biometrics Market By Type, By ... 2011 - 2021", the global biometrics market is projected ... of growing security concerns across various end use sectors ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... of its second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with ... in this eBook by providing practical tips, tools, and strategies for clinical researchers. ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology: